Primary CXCR4 Co-receptor Use in Acute HIV Infection Leads to Rapid Disease Progression in the AE Subtype

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Viral immunology

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/vim.2012.0035PMID 22783935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes.

  2012influential reference
• Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains

  2012cited by this paper
• High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma

  2011cited by this paper
• Genotypic prediction of HIV-1 subtype D tropism

  2011cited by this paper
• R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies

  2011cited by this paper
• Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases

  2011cited by this paper
• HIV-1 Co-Receptor Usage Based on V3 Loop Sequence Analysis: Preferential Suppression of CXCR4 Virus Post HAART?

  2011cited by this paper
• Clinical significance of HIV-1 coreceptor usage

  2011cited by this paper
• Translational Medicine is developing in China: A new venue for collaboration

  2011cited by this paper
• Evidence of dysregulation of dendritic cells in primary HIV infection

  2010cited by this paper
• Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study

  2010cited by this paper
• Low Frequency of CXCR4-Using Viruses in Patients at the Time of Primary Non-Subtype-B HIV-1 Infection

  2010cited by this paper
• High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.

  2010cited by this paper
• Heterosexual Transmission of Human Immunodeficiency Virus Type 1 Subtype C: Macrophage Tropism, Alternative Coreceptor Use, and the Molecular Anatomy of CCR5 Utilization

  2009cited by this paper
• Predicted co-receptor tropism and sequence characteristics of China HIV-1 V3 loops: implications for the future usage of CCR5 antagonists and AIDS vaccine development.

  2009cited by this paper
• Biological properties of HIV-1 subtype B' isolates from infected Chinese blood donors at different disease stages.

  2009cited by this paper
• High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study.

  2009cited by this paper
• Phenotype Variation in Human Immunodeficiency virus Type 1 Transmission and Disease Progression

  2009cited by this paper
• Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism

  2008cited by this paper
• Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

  2008cited by this paper
• Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes

  2008cited by this paper
• HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study.

  2008cited by this paper
• MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

  2007cited by this paper
• Predicting HIV Coreceptor Usage on the Basis of Genetic and Clinical Covariates

  2007cited by this paper
• Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies

  2007cited by this paper
• HIV‐1 coreceptor preference is distinct from target cell tropism: a dual‐parameter nomenclature to define viral phenotypes

  2006cited by this paper
• HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors

  2006cited by this paper
• Determining Human Immunodeficiency Virus Coreceptor Use in a Clinical Setting: Degree of Correlation between Two Phenotypic Assays and a Bioinformatic Model

  2006cited by this paper
• Assessing chemokine co-receptor usage in HIV

  2005cited by this paper
• Co-receptor antagonists as HIV-1 entry inhibitors

  2004cited by this paper
• Human immunodeficiency virus type 1 Brazilian subtype B variant showed an increasing avidity of the anti-V3 antibodies over time compared to the subtype B US/European strain in São Paulo, Brazil.

  2004cited by this paper
• Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1

  2004cited by this paper
• Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

  2003cited by this paper
• Predicting HIV-1 coreceptor usage with sequence analysis.

  2003cited by this paper
• A New Perspective on V3 Phenotype Prediction

  2003cited by this paper
• Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences

  2003cited by this paper
• Variability in the Human Immunodeficiency Virus Type 1 gp120 Env Protein Linked to Phenotype-Associated Changes in the V3 Loop

  2002cited by this paper
• Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.

  2001cited by this paper
• Gender differences in HIV-1 diversity at time of infection

  2000cited by this paper
• Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages).

  2000cited by this paper
• HIV-1 Nomenclature Proposal

  2000cited by this paper
• Structural interactions between chemokine receptors, gp120 Env and CD4.

  1998cited by this paper
• Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1.

  1997cited by this paper
• Analysis of the V3 Loop Sequences from 10 HIV Type 1-Infected AIDS Patients from Paraguay

  1995cited by this paper
• Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population

  1995cited by this paper
• Syncytium-Inducing and Non-Syncytium-Inducing Capacity of Human Immunodeficiency Virus Type 1 Subtypes Other Than B: Phenotypic and Genotypic Characteristics

  1994cited by this paper
• The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.

  1994cited by this paper
• Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.

  1994cited by this paper
• V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability

  1993cited by this paper
• Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

  1993cited by this paper
• Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution

  1992cited by this paper
• Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

  1992cited by this paper

• Distinct genetic clusters in HIV-1 CRF01_AE-infected patients induced variable degrees of CD4+ T-cell loss

  2024cites this paper
• Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals

  2021cites this paper
• Rapid Clinical Progression and Its Correlates Among Acute HIV Infected Men Who Have Sex With Men in China： Findings From a 5-Year Multicenter Prospective Cohort Study

  2021cites this paper
• Methamphetamine Enhances HIV-Induced Aberrant Proliferation of Neural Progenitor Cells via the FOXO3-Mediated Mechanism

  2020cites this paper
• Critical amino acid residues and potential N-linked glycosylation sites contribute to circulating recombinant form 01_AE pathogenesis in Northeast China

  2019cites this paper
• Rapid CD4+ T-cell decline is associated with coreceptor switch among MSM primarily infected with HIV-1 CRF01_AE in Northeast China

  2019cites this paper
• CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.

  2019cites this paper
• Relationships between HIV-mediated chemokine coreceptor signaling, cofilin hyperactivation, viral tropism switch and HIV-mediated CD4 depletion.

  2019cites this paper
• Amino acids at positions 3, 168, and 169 are associated with the ability of Nef proteins from HIV‐1 CRF01_AE to downmodulate CD4

  2017cites this paper
• Higher viral load and genetic diversity of HIV‐1 in seminal compartments than in blood of seven Chinese men who have sex with men and have early HIV‐1 infection

  2017cites this paper
• Coreceptor usage of Chinese HIV-1 and impact of X4/DM transmission clusters among recently infected men who have sex with men

  2016cites this paper
• Acute HIV infection is beneficial for controlling chronic hepatitis B.

  2015cites this paper
• Longitudinal Changes in Plasma Caspase-1 and Caspase-3 during the First 2 Years of HIV-1 Infection in CD4Low and CD4High Patient Groups

  2015cites this paper
• Longitudinal Changes in Total, 2-LTR Circular, and Integrated HIV-1 DNA During the First Year of HIV-1 Infection in CD4Low and CD4High Patient Groups with HIV-1 Subtype AE

  2014influential citation
• Higher HIV DNA in CD4+ Naïve T-Cells During Acute HIV-1 Infection in Rapid Progressors

  2014cites this paper
• Double Negative (DN) [CD3(+)CD4(−)CD8(−)] T cells correlate with disease progression during HIV infection

  2013cites this paper